Genscript Biotech Corporation (HKG:1548)

Genscript Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,444	21,097	42,166	52,563	72,496	22,033
Market Cap Growth	-49.97%	-49.97%	-19.78%	-27.50%	229.03%	-33.64%
Enterprise Value	28,258	18,906	38,022	47,670	64,744	14,836
Last Close Price	12.78	9.84	19.86	24.85	34.50	11.28
PE Ratio	1.19	0.92	-	-	-	-
Forward PE	18.92	-	-	-	-	-
PS Ratio	5.87	4.57	6.43	10.77	18.97	7.27
PB Ratio	0.81	0.63	2.64	4.95	6.70	3.48
P/TBV Ratio	0.63	0.63	3.94	6.85	9.25	3.30
P/OCF Ratio	35.90	35.90	-	-	-	-
PEG Ratio	2.52	2.52	2.52	2.52	2.52	2.52
EV/Sales Ratio	6.12	4.09	5.80	9.77	16.94	4.90
EV/EBITDA Ratio	92.51	34.56	-	-	-	-
EV/EBIT Ratio	262.23	262.23	-	-	-	-
EV/FCF Ratio	-29.98	-	-	-	-	-
Debt / Equity Ratio	0.17	0.17	0.41	0.48	0.30	0.07
Debt / EBITDA Ratio	9.23	9.23	-	-	-	-
Asset Turnover	0.14	0.14	0.28	0.26	0.27	0.34
Inventory Turnover	7.64	7.64	7.59	6.17	5.46	5.60
Quick Ratio	2.40	2.40	4.50	2.99	3.80	2.85
Current Ratio	2.72	2.72	4.76	3.23	3.97	3.03
Return on Equity (ROE)	-5.46%	-5.46%	-20.85%	-31.12%	-47.05%	-47.38%
Return on Assets (ROA)	0.13%	0.13%	-8.76%	-11.45%	-12.88%	-10.94%
Return on Capital (ROIC)	0.15%	0.15%	-10.60%	-14.32%	-17.72%	-20.18%
Return on Capital Employed (ROCE)	0.20%	0.20%	-	-	-	-
Earnings Yield	83.83%	109.05%	-1.77%	-3.36%	-3.86%	-7.21%
FCF Yield	-3.43%	-4.47%	-9.99%	-4.99%	-2.90%	-9.61%
Buyback Yield / Dilution	-3.27%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%
Total Shareholder Return	-3.27%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.